[1]
Mehani, R., Shukla, A., Yadav, V.K. and Sahu, R. 2017. Evolocumab: rising momentum as novel antidyslipidemic drug. International Journal of Basic & Clinical Pharmacology. 6, 7 (Jun. 2017), 1538–1544. DOI:https://doi.org/10.18203/2319-2003.ijbcp20172713.